Ethyl sulfate;20-prop-2-enyltricos-22-enylazanium
C28H57NO4S — CID 153323380
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl sulfate;20-prop-2-enyltricos-22-enylazanium
Ethyl sulfate;20-prop-2-enyltricos-22-enylazanium (PubChem CID 153323380) has the molecular formula C28H57NO4S and a molecular weight of 503.83 g/mol. Its IUPAC name is ethyl sulfate;20-prop-2-enyltricos-22-enylazanium.
Molecular Properties
| Compound Name | Ethyl sulfate;20-prop-2-enyltricos-22-enylazanium |
|---|---|
| PubChem CID | 153323380 |
| Molecular Formula | C28H57NO4S |
| Molecular Weight | 503.83 g/mol |
| Exact Mass | 503.40 |
| IUPAC Name | ethyl sulfate;20-prop-2-enyltricos-22-enylazanium |
| SMILES | C=CCC(CC=C)CCCCCCCCCCCCCCCCCCC[NH3+].CCOS(=O)(=O)[O-] |
| InChI | InChI=1S/C26H51N.C2H6O4S/c1-3-22-26(23-4-2)24-20-18-16-14-12-10-8-6-5-7-9-11-13-15-17-19-21-25-27;1-2-6-7(3,4)5/h3-4,26H,1-2,5-25,27H2;2H2,1H3,(H,3,4,5) |
| InChIKey | NZTBBDBNURWGJB-UHFFFAOYSA-N |
| XLogP | 7.50 |
| TPSA | 94.07 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 503.83 |
| LogP ≤ 5 | 7.50 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'}, {'alert_name': 'sulphate', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153323380 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.